MedPath

Evaluation of DNA damage in anesthesiologists

Not Applicable
Conditions
DNA damage of anesthesiologists.
SP4.011.087.693.339
Registration Number
RBR-4vrz2m
Lead Sponsor
Departamento de Anestesiologia
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Data analysis completed
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Anesthesiologists to compose the exposed group medical and clinical settings to compose the control group; healthy volunteers; both genders; non-smoking; age between 23 to 75 years.

Exclusion Criteria

Malignants diseases; infectious diseases; inflammatory diseases; alcohol consumption; use of tobacco; illicit drug use; use of medications; use of vitamin supplementation; radiation exposure.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
It is expected to find increased DNA damage in the exposed group of participants through the comet assay in lymphocytes analyzed by fluorescence microscopy images with the aid of a software capable of detecting the intensity of the tail, and the higher the tail damage .<br>Increase of cytogenetic damage in the DNA of the exposed participants are also expected by the micronucleus test in the oral mucosa cells, assessed by light microscopy and determined by the presence of micronuclei and nuclear buds by manual counting.<br>The results from both tests are comparative between the exposed and control groups for significant difference check.
Secondary Outcome Measures
NameTimeMethod
Are not expected.
© Copyright 2025. All Rights Reserved by MedPath